Cabergoline prevents the early but not the late onset of ovarian hyperstimulation syndrome (OHSS)

被引：0
|
作者：
Carizza, C. [1 ]
Abdelmassih, V. [1 ]
Melati, I. [1 ]
Ravizzini, P. [1 ]
Salgueiro, L. [1 ]
Santos, E. [1 ]
Lin, T. [1 ]
Colturato, S. [1 ]
Abdelmassih, R. [1 ]
机构：
[1] Clin Ctr Pesquisa Reprod Human Roger Abdelmassih, ART, Sao Paulo, Brazil
来源：
HUMAN REPRODUCTION | 2007年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
O176
引用
收藏
页码：I71 / I71
页数：1
相关论文
共 50 条
  • [1] Early onset of cabergoline therapy for prophylaxis from ovarian hyperstimulation syndrome (OHSS): A potentially safer and more effective protocol
    Gaafar, Sherif
    El-Gezary, Dalal
    El Maghraby, Hassan A.
    [J]. REPRODUCTIVE BIOLOGY, 2019, 19 (02) : 145 - 148
  • [2] The dopamine agonist cabergoline prevents moderate-severe early ovarian hyperstimulation syndrome (OHSS) in high-risk ART patients
    Alvarez, C.
    Bosch, E.
    Melo, M. A. B.
    Fernandez-Sanchez, M.
    Munoz, E. A.
    Remohi, J.
    Simon, C.
    Pellicer, A.
    [J]. HUMAN REPRODUCTION, 2006, 21 : I96 - I96
  • [3] Cabergoline reduces the early onset of ovarian hyperstimulation syndrome: a prospective randomized study
    Carizza, Carlos
    Abdelmassih, Vicente
    Abdelmassih, Soraya
    Ravizzini, Pedro
    Salgueiro, Lister
    Salgueiro, Paulo Tudech
    Jine, Lin Tao
    Nagy, Peter
    Abdelmassih, Roger
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2008, 17 (06) : 751 - 755
  • [4] Cabergoline and Ganirelix Therapy for Early Moderate to Severe Ovarian Hyperstimulation Syndrome (OHSS) Results in Faster Recovery than in Early Untreated OHSS.
    Khan, Z.
    Rollene, N.
    Amols, M.
    Gada, R.
    Coddington, C.
    [J]. FERTILITY AND STERILITY, 2010, 93 (05) : S14 - S14
  • [5] Early severe ovarian hyperstimulation syndrome (OHSS) - case report
    Gross-Kepinska, Katarzyna
    Glodek, Piotr
    Kabatnik, Milena
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2024, 293 : 205 - 205
  • [6] THE EFFECTS OF CABERGOLINE ON OVARIAN HYPERSTIMULATION SYNDROME (OHSS) AND PREGNANCY OUTCOMES ON IN VITRO FERTILIZATION (IVF) PATIENTS
    Gualtieri, M.
    Hoffman, D.
    Barrionuevo, M.
    Christie, D.
    Mouhayar, Y.
    Ory, S. J.
    [J]. FERTILITY AND STERILITY, 2011, 96 (03) : S259 - S260
  • [7] Cabergoline vs intravenous albumin or combination of both for prevention of the early onset ovarian hyperstimulation syndrome
    Soliman, Badeea
    [J]. MIDDLE EAST FERTILITY SOCIETY JOURNAL, 2011, 16 (01) : 56 - 60
  • [8] COMPARISON OF MONTELUKAST AND CABERGOLINE FOR PREVENTION OF OVARIAN HYPERSTIMULATION SYNDROME (OHSS): IN AN EXPERIMENTAL RAT MODEL.
    Akman, L.
    Sahin, G.
    Erbas, O.
    Aktug, H.
    Akdogan, A.
    Goker, E. N. Tavmergen
    [J]. FERTILITY AND STERILITY, 2013, 100 (03) : S51 - S51
  • [9] Re: Ovarian hyperstimulation syndrome (OHSS)
    Sivanesan, K.
    Sabatini, Luca
    Al-Shawaf, Talha
    [J]. OBSTETRICIAN & GYNAECOLOGIST, 2013, 15 (03): : 206 - +
  • [10] Cabergoline for preventing ovarian hyperstimulation syndrome
    Tang, Huilin
    Hunter, Tamara
    Hu, Yongfang
    Zhai, Suo-Di
    Sheng, Xiaoyan
    Hart, Roger J
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (02):
12345